Abstract:Dario Kohlbrenner, 1, 2 Maya Bisang, 1 Sayaka S Aeschbacher, 1 Emanuel Heusser, 1 Silvia Ulrich, 1, 2 Konrad E Bloch, 1, 2 Michael Furian 1, 3 1 Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland; 2 Faculty of Medicine, University of Zurich, Zurich, Switzerland; 3 Swiss University of Traditional Chinese Medicine, Bad Zurzach, Switzerland Correspondence: Michael Furian, Department of Pulmonology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland, Email Study Objectives: To assess the diagnostic accuracy of a purpose-designed QTc-scoring algorithm versus the established hand-scoring in patients with chronic obstructive pulmonary disease (COPD) undergoing sleep studies. Methods: We collected 62 overnight electrocardiogram (ECG) recordings in 28 COPD patients. QT-intervals corrected for heart rate (QTc, Bazett) were averaged over 1-min periods and quantified, both by the algorithm and by cursor-assisted hand-scoring. Hand-scoring was done blinded to the algorithm-derived results. Bland-Altman statistics and confusion matrixes for three thresholds (460, 480, and 500ms) were calculated. Results: A total of 32944 1-min periods and corresponding mean QTc-intervals were analysed manually and by computer. Mean difference between manual and algorithm-based QTc-intervals was − 1ms, with limits of agreement of − 18 to 16ms. Overall, 2587 (8%), 357 (1%), and 0 QTc-intervals exceeding the threshold 460, 480, and 500ms, respectively, were identified by hand-scoring. Of these, 2516, 357, and 0 were consistently identified by the algorithm. This resulted in a diagnostic classification accuracy of 0.98 (95% CI 0.98/0.98), 1.00 (1.00/1.00), and 1.00 (1.00/1.00) for 460, 480, and 500ms, respectively. Sensitivity was 0.97, 1.00, and NA for 460, 480, and 500ms, respectively. Specificity was 0.98, 1.00, and 1.00 for 460, 480, and 500ms, respectively. Conclusion: Overall, 8% of nocturnal 1-min periods showed clinically relevant QTc prolongations in patients with stable COPD. The automated QTc-algorithm accurately identified clinically relevant QTc-prolongations with a very high sensitivity and specificity. Using this tool, hospital sleep laboratories may identify asymptomatic patients with QTc-prolongations at risk for malignant arrhythmia, allowing them to consult a cardiologist before an eventual cardiac event. Keywords: QTc, long-QT syndrome, COPD, algorithm, validity, ECG Cardiovascular comorbidity is frequent in chronic obstructive pulmonary disease (COPD) 1 and becomes more prevalent with progressing disease. 2 In fact, individuals with COPD are more prone to die from cardiovascular disease than from COPD itself. 3 Estimating the risk of cardiovascular events, the heart rate corrected QT-interval (QTc) is widely used. The QT-interval describes the repolarization time of the heart from the beginning of the QRS-complex to the end of the T-wave. Corrected for heart rate, QTc is expressed. 4,5 QT-intervals are recorded with an electrocardiogram (ECG), which patients with cardiopulmonary disorders undergo on a regular basis. Pathologically prolonged QTc are >460 ms in symptomatic and >480 ms in asymptomatic individuals. 6 Values exceeding these thresholds reveal an increased probability for a long-QT syndrome (LQTS), which might manifest with life-threatening arrhythmia. A QTc >500 ms is considered highly pathological in both men and women and poses an increased risk for, potentially fatal, torsade de pointes tachycardies. 6,7 Usually, LQTS is acquired due to disease progression, decreased physical activity, the intake of QT-prolonging drugs, or electrolytic imbalance. 8,9 Given this multifactorial development, a comprehensive clinical assessment is needed. Although specific pathophysiological pathways remain to be elucidated, COPD patients are at increased risk for prolonged QTc, especially during acute exacerbations. 10,11 Impaired lung function, and thus the majority of cardiorespiratory disorders, is associated with increased cardiovascular comorbidity and mortality. 12–14 Accordingly, QTc is an important marker regarding cardiovascular comorbidity risk in COPD and is widely acknowledged in clinical practice. Sleep studies are frequently required in patients with COPD. Thus, they would provide a widely available opportunity for LQTS screening in patients with COPD since continuous ECG is recorded alongside. In addition, QTc shows considerable variability over the course of a recording. Sampling for a longer duration (ie, overnight) will thus lead to a more accu -Abstract Truncated-

Use of portable single‐lead electrocardiogram device as an alternative for QTc monitoring in critically ill patients

Computerized QT and QTc Measurements From Bedside ICU Monitors Are Similar to Those Derived From a Standard 12‐Lead ECG

Handheld QTc Interval Monitoring in Resource-Limited Settings

KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review

Continuous QTc Monitoring for Patients Intoxicated with QTc Prolonging Medication in the Emergency Department: A Proof of Principle Study

Validating QT-Interval Measurement Using the Apple Watch ECG to Enable Remote Monitoring During the COVID-19 Pandemic

Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study

Relevance of accurate QT correction in the assessment of long QT syndrome

Prevalence and predictors of false positive QTc prolongation by the automated measurement

Clinical Aspects of Type 3 Long-QT Syndrome: an International Multicenter Study.

Automated Quantification of QT-Intervals by an Algorithm: A Validation Study in Patients with Chronic Obstructive Pulmonary Disease

Proceed with caution: Standard protocol exercise stress tests fail to replicate the diagnostic utility of supine-stand tests for long QT syndrome

Serum Magnesium Levels and QTc Interval Prolongation As Prognostic Markers in Acute Myocardial Infarction: A Randomized Controlled Study

Use of ECG monitoring for adult patients taking high-risk QT interval-prolonging drugs in clinical practice: a systematic review protocol

Utilizing median and maximum QTc values improves prediction of breakthrough cardiac events in pediatric long QT syndrome

Evaluation of the analytical and clinical performance of a high-sensitivity troponin I point-of-care assay in the Mersey Acute Coronary Syndrome Rule Out Study (MACROS-2)

Patient Driven EKG Device Performance in Adults with Fontan Palliation

Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients

Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data

Prevalence and prognostic significance of long QT interval in patients with acute coronary syndrome: review of the literature

Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients